Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BBB Foods Inc. Class A Common Shares (NY:TBBB)

28.98 -0.08 (-0.28%)
Streaming Delayed Price Updated: 1:21 PM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BBB Foods Inc. Class A Common Shares

< Previous 1 2 Next >
Stocks Falter, Metals Fall As Traders Turn Cautious Ahead Of Fed Minutes, Nvidia Earnings; First Solar Hits Record Highs: What's Driving Markets Wednesday?
Wall Street experienced a muted session on Wednesday morning as traders adopted a cautious stance ahead of the Federal Reserve meeting minutes release at 2 p.m. EDT and Nvidia Corp. 
Via Benzinga
Topics Economy
Exposures Interest Rates
TBBB Invites You to Join Its First Quarter 2024 Earnings Conference Call
From Tiendas 3B
Via Business Wire
BBB Foods Inc. Announces the Filing of its Annual Report on Form 20-F for Fiscal Year 2023
From Tiendas 3B
Via Business Wire
12 Consumer Staples Stocks Moving In Friday's Intraday Session
Via Benzinga
Tiendas 3B 4Q23 & FY2023 Earnings Release
From Tiendas 3B
Via Business Wire
Tiendas 3B Announces New Time for Its Full Year and Fourth Quarter 2023 Earnings Conference Call
From Tiendas 3B
Via Business Wire
Tiendas 3B Invites You to Join Its Full Year and Fourth Quarter 2023 Earnings Conference Call
From Tiendas 3B
Via Business Wire
Top 5 Defensive Stocks That May Plunge This Quarter
As of March 25, 2024, five stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
IPO Revival In 2024: Plaid, Chime, And Kim Kardashian's Skims Among Potential Market Movers
Market for IPOs expected to rebound in 2024 after inflation & interest rate rise hit new listings in 2022-23. 2023 saw 50% decrease in IPOs globally. 
Via Benzinga
Topics Economy Initial Public Offering
Exposures Interest Rates Securities Market
Gilead-Backed Kyverna Overshoots Raised IPO Expectations
Kyverna Therapeutics raised almost $320 million in its initial public offering, which was priced above the marketed range. Backed by Gilead Sciences, the company's offering was the second largest for a... 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.